Претрага

Резултати

Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia [2012]

Karan-Đurašević, Teodora ; Palibrk, Vuk; Kostić, Tatjana ; Spasovski, Vesna ; Nikčević, Gordana ; Srzentić Dražilov, Sanja ; Colovic, Milica; Čolović, Nataša ; Vidović, Ana ; Antić, Darko ;

Mihaljević, Biljana ; Pavlović, Sonja ; Tošić, Nataša ;

Assessment of Symptom Burden in Patients with Hematologic Malignancies using Edmonton Symptom Assessment System (ESAS) at the Time of Admission to the Institute for Oncology and Radiology of Serbia (IORS) as a Treatment Tailoring Concept [2019]

Dimitrijevic, Jelena

Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients [2017]

Marjanović, Irena M. ; Karan-Đurašević, Teodora Ž. ; Ugrin, Milena M. ; Virijević, Marijana M. ; Vidović, Ana D. ; Tomin, Dragica S. ; Suvajdžić-Vuković, Nada D. ; Pavlović, Sonja T. ; Tošić, Nataša M.

The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings [2023]

Sretenović, Aleksandra M.; Mitrović, Marko; Vukosavljević, Nikola; Kecman, Natalija; Jovanović, Jelica V.; Bukumirić, Zoran M. ; Bila, Jelena S.

The Use of PET/CT in Radiotherapy Planning in Young Women with Hodgkin's Lymphoma [2019]

Mitric-Askovic, Milana; Licina, Jelena T ; Ivanov, Olivera ; Baucal, Milutin D

Prognostic impact of response-adjusted ISS score in Multiple Myeloma [2021]

Mitrović, Marko; Bukumirić, Zoran M. ; Sretenović, Aleksandra M.; Miketić, Ivana; Bila, Jelena S.

Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma [2016]

Bila, Jelena ; Sretenovic, Aleksandra; Jelicic, Jelena ; Tošić, Nataša ; Glumac, Irena ; Fekete, Marija Dencic; Antić, Darko ; Todorović, Milena ; Marković, Olivera ; Milojevic, Zoran;

Radojković, Milica ; Trajković, Goran ; Puric, Mila; Pavlović, Sonja ; Mihaljević, Biljana ;

Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy [2017]

Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Tijanić, Ivan

Ultra-high-risk prognostic significance of double and triple hit myeloma [2021]

Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A.

Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy [2023]

Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S. ; Schjesvold, Fredrik; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hajek, Roman; Usenko, Hanna;

Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;